Cargando…
Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion
A 9-year-old boy developed progressive anthracycline-induced cardiomyopathy three months after completion of chemotherapy for osteosarcoma. Five months after completion of chemotherapy, at the age of 10 years, heart transplantation was performed. At 29 months since transplantation, the patient remai...
Autores principales: | Kaskinen, Anu K., Helle, Emmi, Pihkala, Jaana, Jahnukainen, Timo, Kanerva, Jukka, Mäyränpää, Mikko I., Lemström, Karl, Mattila, Ilkka, Ojala, Tiina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571779/ https://www.ncbi.nlm.nih.gov/pubmed/34766017 http://dx.doi.org/10.1016/j.jaccas.2021.07.004 |
Ejemplares similares
-
Rare Variants in Genes Associated With Cardiomyopathy Are Not Common in Hypoplastic Left Heart Syndrome Patients With Myocardial Dysfunction
por: Helle, Emmi, et al.
Publicado: (2020) -
Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
por: Kaskinen, Anu K., et al.
Publicado: (2023) -
Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients
por: Jahnukainen, Timo, et al.
Publicado: (2019) -
Risk factors for mortality in patients with hypoplastic left heart syndrome after the Norwood procedure
por: Selenius, Sabina, et al.
Publicado: (2023) -
Hypertrophic Midventricular Obstructive Cardiomyopathy Revealed by a Stroke
por: Habis, Michel, et al.
Publicado: (2019)